Matches in SemOpenAlex for { <https://semopenalex.org/work/W4250652502> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W4250652502 endingPage "S153" @default.
- W4250652502 startingPage "S152" @default.
- W4250652502 abstract "Early stage Hodgkin lymphoma (HL) is a rare disease and the location of lymphoma varies extensively between patients. This represents a clinical challenge as the quality of radiation therapy (RT) is partly dependent upon the patient volumes and the experience of the treating center. In this study, we evaluate the variability of RT plans by 4 International Lymphoma Radiation Oncology Group (ILROG) centers by field technique, planning parameters and estimated doses to organs at risk (OARs). Nine patients with stage I-II classical HL with masses of different size and location were selected. Based on the clinical information, 4 ILROG centers were asked to fashion RT plans to a prescribed dose of 30.6 Gy in 1.8-2 Gy fractions. A post-chemotherapy CT-scan with a clinical target volume (CTV) adapted from the pre-chemotherapy FDG-PET-CT scan as well as pre-contoured OARs was provided for each patient. The treatment technique and planning methods were chosen according to each center's best practice in 2013. Two patients were stage I, 5 presented with mediastinal disease, and 3 with disease in the neck only. Four patients were male, median age at diagnosis was 35 years (range: 22-74 years). The median CTV was 85.8 cm3 (range: 19.3-462.9 cm3). Of the resulting 36 RT plans, 15 were planned with 3D conformal RT (2 parallel-opposed/angled fields or 3 fields), 15 with IMRT (4-9 fields), 5 with VMAT, and 1 with 3D conformal RT/IMRT. The variations in CTV-to-planning target volume (PTV) margins (1-1.5 cm), field arrangements, maximum tolerated dose, and plan conformity (conformity index = V98%/PTV) were substantial. Five plans did not adhere to current ILROG guidelines. Estimated doses to OARs were comparable between centers. Dose estimates and plan parameters are presented in Table 1. RT planning for HL is challenging due to the heterogeneity in size and location of disease and, additionally, the variation in choice of treatment technique and field arrangements. Despite of the variation between 4 ILROG centers, there was an acceptable and comparable dose to the critical OARs. Adopting ILROG guidelines and implementing universal dose objectives could further standardize treatment techniques and contribute to lower the dose to the surrounding normal tissues.Oral Scientific Abstract 337; Table 1Dose Estimates and Plan Parameters for 9 HL Patients Planned by 4 ILROG CentersCenter 1Center 2Center 3Center 4median (range)median (range)median (range)median (range)Heart mean dose [Gy)1.0 (0-11.6)0.5 (0-9.8)1.2 (0-14.9)0.8 (0-10)Lung mean dose [Gy]6.5 (0-13.9)4.9 (0-11.4)6.5 (0-15.2)6.2 (0-13.5)Breast mean dose [Gy]0.3 (0-8.3)0.3 (0-7.5)0.3 (0-9.2)0.4 (0-8.9)Thyroid mean dose [Gy]14.0 (0.4-28.5)12.3 (0.2-30.4)17.4 (0.5-31.7)14.9 (0.3-31.8)PTV [cm3]500.2 (65.6-1668.4)388.8 (94-1504.6)799.7 (127.9-3056.8)468.4 (94.7-1864.4)Dmax [Gy]32.7 (30.8-34.1)35.4 (30.6-38.6)33.6 (32.8-35)32.8 (32.2-35.2)V30 Gy [cm3]272.3 (8.8-1778.9)427.5 (0.1-1511.3)1224.5 (108.2-5524)450.9 (82.4-2250)Conformity index1.0 (0.1-2.3)1.5 (0-2.3)1.8 (0.8-2.1)0.9 (0.8-1.3) Open table in a new tab" @default.
- W4250652502 created "2022-05-12" @default.
- W4250652502 creator A5007688820 @default.
- W4250652502 creator A5010185376 @default.
- W4250652502 creator A5014347189 @default.
- W4250652502 creator A5030249904 @default.
- W4250652502 creator A5045287861 @default.
- W4250652502 creator A5047308821 @default.
- W4250652502 creator A5053601327 @default.
- W4250652502 creator A5058851717 @default.
- W4250652502 creator A5085683325 @default.
- W4250652502 date "2014-09-01" @default.
- W4250652502 modified "2023-10-14" @default.
- W4250652502 title "Radiation Therapy Planning for Early Stage Hodgkin Lymphoma: Experiences of the International Lymphoma Radiation Oncology Group" @default.
- W4250652502 doi "https://doi.org/10.1016/j.ijrobp.2014.05.631" @default.
- W4250652502 hasPublicationYear "2014" @default.
- W4250652502 type Work @default.
- W4250652502 citedByCount "0" @default.
- W4250652502 crossrefType "journal-article" @default.
- W4250652502 hasAuthorship W4250652502A5007688820 @default.
- W4250652502 hasAuthorship W4250652502A5010185376 @default.
- W4250652502 hasAuthorship W4250652502A5014347189 @default.
- W4250652502 hasAuthorship W4250652502A5030249904 @default.
- W4250652502 hasAuthorship W4250652502A5045287861 @default.
- W4250652502 hasAuthorship W4250652502A5047308821 @default.
- W4250652502 hasAuthorship W4250652502A5053601327 @default.
- W4250652502 hasAuthorship W4250652502A5058851717 @default.
- W4250652502 hasAuthorship W4250652502A5085683325 @default.
- W4250652502 hasBestOaLocation W42506525021 @default.
- W4250652502 hasConcept C126322002 @default.
- W4250652502 hasConcept C126838900 @default.
- W4250652502 hasConcept C143998085 @default.
- W4250652502 hasConcept C146357865 @default.
- W4250652502 hasConcept C151730666 @default.
- W4250652502 hasConcept C201645570 @default.
- W4250652502 hasConcept C2776694085 @default.
- W4250652502 hasConcept C2779338263 @default.
- W4250652502 hasConcept C2989005 @default.
- W4250652502 hasConcept C2992520072 @default.
- W4250652502 hasConcept C2992779791 @default.
- W4250652502 hasConcept C509974204 @default.
- W4250652502 hasConcept C71924100 @default.
- W4250652502 hasConcept C86803240 @default.
- W4250652502 hasConceptScore W4250652502C126322002 @default.
- W4250652502 hasConceptScore W4250652502C126838900 @default.
- W4250652502 hasConceptScore W4250652502C143998085 @default.
- W4250652502 hasConceptScore W4250652502C146357865 @default.
- W4250652502 hasConceptScore W4250652502C151730666 @default.
- W4250652502 hasConceptScore W4250652502C201645570 @default.
- W4250652502 hasConceptScore W4250652502C2776694085 @default.
- W4250652502 hasConceptScore W4250652502C2779338263 @default.
- W4250652502 hasConceptScore W4250652502C2989005 @default.
- W4250652502 hasConceptScore W4250652502C2992520072 @default.
- W4250652502 hasConceptScore W4250652502C2992779791 @default.
- W4250652502 hasConceptScore W4250652502C509974204 @default.
- W4250652502 hasConceptScore W4250652502C71924100 @default.
- W4250652502 hasConceptScore W4250652502C86803240 @default.
- W4250652502 hasIssue "1" @default.
- W4250652502 hasLocation W42506525021 @default.
- W4250652502 hasOpenAccess W4250652502 @default.
- W4250652502 hasPrimaryLocation W42506525021 @default.
- W4250652502 hasRelatedWork W1967003708 @default.
- W4250652502 hasRelatedWork W2007765177 @default.
- W4250652502 hasRelatedWork W2016021873 @default.
- W4250652502 hasRelatedWork W2048191209 @default.
- W4250652502 hasRelatedWork W2355670240 @default.
- W4250652502 hasRelatedWork W2362144381 @default.
- W4250652502 hasRelatedWork W2376593068 @default.
- W4250652502 hasRelatedWork W2411610896 @default.
- W4250652502 hasRelatedWork W4220939315 @default.
- W4250652502 hasRelatedWork W4291189777 @default.
- W4250652502 hasVolume "90" @default.
- W4250652502 isParatext "false" @default.
- W4250652502 isRetracted "false" @default.
- W4250652502 workType "article" @default.